2026· Journal of Engineering, Science and Technological Trends· pp. 1-8· 0 citations
TL;DR
The literature supports AI as a developing decision-support tool that complements, rather than replaces, ophthalmic assessment, and further research should prioritise validation of AI-based tools in multi-centre settings, transparent documentation of errors and uncertainty, and prospective testing of systems intended for real-time clinical use.
Abstract
Glaucoma remains a leading cause of irreversible visual disability worldwide, largely because structural damage to the optic nerve can progress substantially before a patient notices any vision change. Computer-aided diagnosis (CAD) using deep learning has therefore been explored as a strategy to support earlier identification, drawing on fundus photography, optical coherence tomography (OCT), visual field testing, and combinations of these modalities. This structured review discusses recent studies on AI-assisted detection in glaucoma management and considers their practical significance for clinical care. According to the literature reviewed, convolutional neural networks (CNNs) play a clear role in glaucoma screening, explicit segmentation models support assessment of the optic disc and cup, and OCT-based methods represent structural change more directly than surface imaging alone. Multimodal approaches, three-dimensional OCT analysis, transformer architectures, and progression-tracking models represent active and promising directions. However, clinical translation remains constrained by biased or geographically narrow datasets, device-specific variation, limited external validation, and unresolved questions about the reliability of individual predictions. The literature therefore supports AI as a developing decision-support tool that complements, rather than replaces, ophthalmic assessment. Further research should prioritise validation of AI-based tools in multi-centre settings, transparent documentation of errors and uncertainty, and prospective testing of systems intended for real-time clinical use.
A systematic comparative evaluation of three deep learning-based segmentation architectures — U-Net, U-Net++, and Y-Net — for automated identification of DME and Intraretinal Fluid regions in OCT scans demonstrates the feasibility of deep learning-based OCT segmentation as a diagnostic support tool in resource-constrai...
Dhiraj Pyakurel, Yokisha Poudel, Sushiksha Prasai et al.· Journal of Hillside College...· 0 citations
Glaucoma is a leading cause of blindness globally, making early diagnosis and treatment critical for vision preservation. The advancement of deep learning has accelerated progress in medical image recognition, which offers new possibilities for intelligent diagnosis. This paper outlines the research background and sign...
Zheng-Rong Li· International Journal of Pub...· 0 citations
This study systematically evaluated trade-offs between diagnostic performance, structural complexity and clinical calibration across convolutional neural networks (CNNs) to identify optimal frameworks for mobile health glaucoma screening.
In order to identify age-related macular degeneration (AMD), researchers have recently developed new deep learning (DL) models that use a single visual modality. The most crucial modalities for examining AMD in clinical settings are retinal fundus and optical coherence tomography (OCT) images. It is unclear whether usi...
J. Padma· Natural Resources for Human...· 0 citations
Automated analysis of retinal fundus photographs has become an important research direction for computer-aided ophthalmic screening. However, many existing deep-learning studies focus on a single disease, particularly diabetic retinopathy, or emphasize disease presence without integrating severity assessment. This stud...
S. Shinde· Journal of Intelligent Decis...· 0 citations
This study presents a novel machine-learning–based framework for automated AMD detection and exploratory severity grading using Optical Coherence Tomography images, which has the potential to support clinical decision–making and enhance personalized disease management.
Ahmad Ryad Soobhany, Mohammed Thafheem· Frontiers in Imaging· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.